Are you confused about how best to comply with the FDA final rule on IND safety reporting? Would you like to hear more about how to handle common, yet challenging, safety reporting situations? Do you know someone who is interested?
CTTI invites you to participate in a webinar hosted by the IND Safety Advancement Project Team. This webinar is the first in a CTTI-hosted series designed to explore challenging safety reporting scenarios using case studies. We encourage you to share this invitation to others who may be interested in learning more about IND safety reporting.
Topic: Case Studies on Expedited IND Safety Reporting
Date: Thursday, April 21, 2016
Time: 12:00 p.m. – 1:00 p.m. EST
Presenters:
- Patrick Archdeacon, Senior Clinical Advisor, Office of Medical Policy, Food and Drug Administration, Center for Drug Evaluation and Research
- Annemarie Forrest, Associate Director of Projects, CTTI
- Nina Stuccio, Head, Medical Safety Review, Global Clinical Safety & Pharmacovigilance, Merck, Inc.
WebEx Link
Meeting number: 735 340 171
Meeting password: ctti
After you connect to meeting website, please follow step-by-step instructions for connecting to the audio. If you prefer to connect to audio only, you can join by phone at:
1-855-244-8681 Call-in toll-free number (US/Canada)
1-650-479-3207 Call-in toll number (US/Canada)
Access code: 735 340 171